PLCEI Mutations and New Genes in FSGS
Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Friedhelm Hilderbrant |
Contact phone | 734-764-7145 |
Contact email | fhilde@med.umich.edu |
Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Friedhelm Hilderbrant |
Contact phone | 734-764-7145 |
Contact email | fhilde@med.umich.edu |